Dan X, Li K, Xu J, & Yan P. (2024). The Potential of Neuregulin 4 as a Novel Biomarker and Therapeutic Agent for Vascular Complications in Type 2 Diabetes Mellitus. Dove Medical Press.
Chicago Style (17th ed.) CitationDan X, Li K, Xu J, and Yan P. The Potential of Neuregulin 4 as a Novel Biomarker and Therapeutic Agent for Vascular Complications in Type 2 Diabetes Mellitus. Dove Medical Press, 2024.
MLA (9th ed.) CitationDan X, et al. The Potential of Neuregulin 4 as a Novel Biomarker and Therapeutic Agent for Vascular Complications in Type 2 Diabetes Mellitus. Dove Medical Press, 2024.
Warning: These citations may not always be 100% accurate.